MAPT and Alzheimer disease: As mentioned above, the exact succession of pathogenic events in AD is still unclear; Aβ and tau may be causative, but subtler prior changes in neuronal connectivity, metabolic patterns and inflammation could represent an early disruption of neuronal function, leading to secondary accumulation of Aβ and tau [36].